BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2479397)

  • 1. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
    Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
    Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of antitumor immune responses by bleomycin].
    Morikawa K
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
    Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
    Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
    Xu ZY
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin].
    Hosokawa M; Morikawa K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2700-8. PubMed ID: 6210061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
    Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
    Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
    Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
    Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of suppressor activity and effector activity of tumor-bearing hosts by bleomycin].
    Hosokawa M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):677-83. PubMed ID: 2421642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel.
    Morikawa K; Okada F; Hosokawa M; Kobayashi H
    Cancer Res; 1987 Jan; 47(1):37-41. PubMed ID: 3491675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y; Sendo F; Miyake T; Kobayashi H
    J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
    Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H
    Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells.
    Hollingsworth MA; Evans DL
    J Natl Cancer Inst; 1984 Jun; 72(6):1357-63. PubMed ID: 6233443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery.
    Shibata T; Suzuki K; Yamashita T; Takeichi N; Mark M; Hosokawa M; Kobayashi H; Arisue M
    Anticancer Res; 1998; 18(4A):2483-6. PubMed ID: 9703896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
    Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
    Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immunosuppressor cells induced by immunization of solubilized tumor-associated antigens prepared from a rat fibrosarcoma.
    Minami A
    Nihon Seikeigeka Gakkai Zasshi; 1981 Aug; 55(8):779-92. PubMed ID: 6171602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
    Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
    Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in spleen suppressor cell content in rats with progressing and regressing tumors.
    Hollingsworth MA; Evans DL
    J Natl Cancer Inst; 1982 Jul; 69(1):53-8. PubMed ID: 6212710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
    Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
    Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.